124018 Sigma-AldrichAkt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2, CAS 612847-09-3, is a cell-permeable, reversible & selective inhibitor of Akt1/Akt2 (IC50 = 58 nM and 210 nM for Akt1 & Akt2, respectively),
More>> Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2, CAS 612847-09-3, is a cell-permeable, reversible & selective inhibitor of Akt1/Akt2 (IC50 = 58 nM and 210 nM for Akt1 & Akt2, respectively), Less<<MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
Synonyms: 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one, Akti-1/2
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| CAS # | Empirical Formula |
|---|---|
| 612847-09-3 | C₃₄H₂₉N₇O |
Products
| Catalogue Number | Packaging | Qty/Pack | |
|---|---|---|---|
| 124018-1MGCN | 塑膠安瓿;塑膠針藥瓶 | 1 mg | |
| 124018-5MGCN | 玻璃瓶 | 5 mg |
| Description | |
|---|---|
| Overview | A cell-permeable and reversible quinoxaline compound that potently and selectively inhibits Akt1/Akt2 activity (IC50 = 58 nM, 210 nM, and 2.12 µM for Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays). The inhibition appears to be pleckstrin homology (PH) domain-dependent. It does not exhibit any inhibitory effect against PH domain-lacking Akts, or other closely related AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50 µM. Overcomes Akt1/Akt2-mediated resistance to chemotherapeutics in tumor cells and is shown to block basal and stimulated phosphorylation/activation of Akt1/Akt2 both in cultured cells in vitro and in mice in vivo. A 10 mM (1 mg/181 µl) solution of Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 (Cat. No. 124017) in DMSO is also available. |
| Catalogue Number | 124018 |
| Brand Family | Calbiochem® |
| Synonyms | 1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one, Akti-1/2 |
| Product Information | |
|---|---|
| CAS number | 612847-09-3 |
| ATP Competitive | N |
| Form | Yellow solid |
| Hill Formula | C₃₄H₂₉N₇O |
| Chemical formula | C₃₄H₂₉N₇O |
| Reversible | Y |
| Structure formula Image | |
| Quality Level | MQ200 |
| Biological Information | |
|---|---|
| Primary Target | Akt1, Akt2, Akt3 |
| Primary Target IC<sub>50</sub> | 58 nM, 210 nM, 2.12 µM against Akt1, Akt2, and Akt3, respectively, in in vitro kinase assays |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 124018-1MGCN | 07790788048006 |
| 124018-5MGCN | 04055977205718 |
Documentation
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem MSDS
| Title |
|---|
Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 - CAS 612847-09-3 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 124018 |
References
| Reference overview |
|---|
| Calleja, V., et al. 2009. PLoS Biol. 7, e17. Logie, L., et al. 2007. Diabetes 56, 228. Barnett, S.F., et al. 2005. Biochem. J. 385, 399. DeFeo-Jones, D., et al. 2005. Mol. Cancer Ther. 4, 271. Zhao, Z., et al. 2005. Bioorg. Med. Chem. Lett. 15, 905. Lindsley, C.W., et al. 2005. Bioorg. Med. Chem. Lett. 15, 761. |
Brochure
| Title |
|---|
| Akt |
Posters
| Title |
|---|
| Human Kinome & InhibitorSelect™ Libraries |